QSYMIA: payments to doctors
Payments that named QSYMIA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3M
- Providers
- 5,815
- Transactions
- 14,222
- Average per transaction
- $207
The per-transaction average — $207 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,815 providers the average total is $507, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Vivus LLC | $1,923,623 | 65.2% |
| Vivus, Inc. | $1,027,012 | 34.8% |